.png)
Sleep apnea is a sleep disorder in which breathing repeatedly stops during sleep — with each pause lasting 10+ seconds and occurring 5+ times per hour. The most common form, obstructive sleep apnea (OSA), is caused by airway collapse; the less common central form involves the brain failing to signal breathing at all. An estimated 1 billion people globally have OSA — and approximately 80% are undiagnosed, making it the leading silent driver of daytime fatigue, cardiovascular disease, and mood disruption. It requires medical evaluation and treatment: behavioral sleep programs address the insomnia layer that OSA often creates, but do not treat the breathing disorder itself.
The Condition What Is Sleep Apnea?
Sleep apnea is a sleep-related breathing disorder characterized by repeated pauses in breathing during sleep, each lasting 10 seconds or more. These events — called apneas — cause drops in blood oxygen, surges in blood pressure, and partial brain arousal that fragments sleep architecture throughout the night. In most cases, the person never fully wakes and has no awareness of the disruptions — which is why the condition often goes undiagnosed for years.
Sleep apnea severity is classified by the Apnea-Hypopnea Index (AHI) — the number of breathing pauses per hour of sleep. Mild OSA is defined as 5–14 events per hour; moderate as 15–29; and severe as 30 or more. Someone with severe OSA may stop breathing hundreds of times per night. The cumulative effect on sleep architecture — particularly the suppression of slow-wave and REM sleep — produces the chronic fatigue, cognitive impairment, and mood disturbance that characterize the condition.
The most common reason sleep apnea goes undiagnosed: Most people with OSA assume their fatigue, morning headaches, and poor concentration are caused by stress, aging, or simply "not being a morning person." Snoring is often normalized by both the patient and their partner. Research in The Lancet estimates that 80% of people with clinically significant OSA have never received a diagnosis. If you wake tired despite adequate time in bed and snore — get tested.
Three Distinct Conditions The Three Types of Sleep Apnea
The most prevalent form — affecting an estimated 1 billion people globally. OSA occurs when the muscles of the upper airway (particularly the throat and base of tongue) relax excessively during sleep, causing the airway to narrow or completely collapse. The brain detects falling oxygen levels and generates a partial arousal — often accompanied by a snort, gasp, or body jerk — just enough to restore airway muscle tone and resume breathing. The person rarely fully wakes, but each arousal fragments sleep architecture. This cycle can repeat hundreds of times per night.
Central sleep apnea is a neurological disorder — the brainstem fails to transmit the signal to the respiratory muscles to breathe. Unlike OSA, there is no airway obstruction; the effort to breathe stops entirely. CSA is less common than OSA and is most often associated with heart failure (Cheyne-Stokes breathing pattern), opioid medication use, brainstem stroke, or high altitude. Treatment differs significantly from OSA — PAP therapy variants that deliver rescue breaths (ASV or BiPAP with backup rate) are typically required.
Also called treatment-emergent central sleep apnea — complex sleep apnea presents as OSA that, when treated with standard CPAP therapy, reveals an underlying central apnea component that was previously masked by the obstructive events. In some cases, the CPAP pressure itself may trigger central events. This presentation requires evaluation by a sleep specialist and typically management with adaptive servo-ventilation (ASV) or BiPAP with backup rate rather than standard CPAP.
Who Gets It Risk Factors for Sleep Apnea
While anyone can develop sleep apnea, certain factors substantially increase risk. Understanding these helps identify who should be proactively screened rather than waiting for a partner to report nighttime symptoms.
- Obesity or excess weight — the most modifiable risk factor; fat deposits around the upper airway narrow the lumen
- Male sex (2–3× higher risk than women before menopause; risk equalizes post-menopause)
- Age 40+ (prevalence increases significantly with age)
- Thick neck circumference (>17" in men, >16" in women)
- Retrognathia (recessed jaw) or other craniofacial anatomy
- Family history of sleep apnea
- Smoking (increases airway inflammation)
- Alcohol and sedative use (relaxes airway muscles)
- Nasal congestion or structural obstruction
- Hypothyroidism, acromegaly, polycystic ovary syndrome
- Heart failure (Cheyne-Stokes respiration is a common CSA variant)
- History of stroke affecting the brainstem
- Long-term opioid medication use
- High altitude (hypoxia-induced periodic breathing)
- Male sex and older age
- Renal failure
- Brainstem neurological conditions
Why It Matters Health Consequences of Untreated Sleep Apnea
Each apnea event produces a brief but significant physiological stress response: blood oxygen drops, blood pressure surges, heart rate becomes erratic, and the brain partially arouses. Multiplied by hundreds of events per night, year after year, the cumulative cardiovascular and metabolic consequences are substantial.
OSA is independently associated with a significantly elevated risk of hypertension — approximately 3× higher than the general population in severe cases. The repeated nocturnal blood pressure surges directly stress arterial walls and the heart. Research in the European Respiratory Journal links untreated OSA to elevated risks of atrial fibrillation, heart attack, and stroke.
Sleep fragmentation and nocturnal hypoxia both impair insulin sensitivity and glucose metabolism. Research in Sleep shows OSA is independently associated with increased Type 2 diabetes risk, even after controlling for obesity — suggesting mechanisms beyond the shared risk factor of excess weight.
The chronic sleep fragmentation of OSA impairs prefrontal regulatory function — producing the same emotional dysregulation, irritability, and mood effects as general sleep deprivation, but sustained indefinitely. Depression prevalence is significantly elevated in OSA patients, and treating OSA with CPAP produces meaningful improvements in both mood and cognitive function.
OSA-related daytime sleepiness produces driving impairment comparable to alcohol intoxication. Research in Sleep finds OSA patients have significantly elevated motor vehicle accident rates. Many patients are unaware of their impairment — having adapted to feeling chronically sub-alert without recognizing it as abnormal.
Repeated oxygen desaturation events affect multiple organ systems beyond the cardiovascular. Non-alcoholic fatty liver disease (NAFLD) is elevated in OSA patients through hypoxia-driven liver inflammation. Pulmonary hypertension can develop in severe untreated OSA. The kidneys are also affected through the proteinuria associated with chronic nocturnal hypoxia.
OSA's characteristic loud snoring, gasping, and body movements frequently disturb bed partners — producing secondary sleep deprivation for the partner that compounds relationship strain. Partners are often the first to notice apneic events and are a critical diagnostic resource. Many couples resort to separate bedrooms, with significant relationship consequences.
Getting Tested How Sleep Apnea Is Diagnosed
Sleep apnea cannot be diagnosed from symptoms alone — objective sleep testing is required. The two primary diagnostic pathways are:
At-Home Sleep Apnea Test (HSAT)
A portable monitoring device worn during sleep at home that measures: nasal airflow, respiratory effort, blood oxygen saturation (SpO₂), and heart rate. HSATs are convenient, less expensive, and sufficient to diagnose straightforward moderate-to-severe OSA in otherwise healthy adults. Limitations: they may underestimate severity (recording only time awake, not total sleep time), sensors can be displaced, and they cannot diagnose other sleep disorders or measure sleep stages. Not appropriate for children, those with significant cardiorespiratory comorbidities, or suspected complex sleep apnea.
Overnight Polysomnography (PSG)
The gold-standard comprehensive sleep study conducted at a sleep laboratory. PSG monitors: brain activity (EEG), eye movements (EOG), muscle tone (chin EMG), leg movements, nasal and oral airflow, chest and abdominal respiratory effort, blood oxygen saturation, heart rate (ECG), and body position — all simultaneously across the full sleep period. PSG provides a complete picture of sleep architecture, accurately classifies sleep stages, and can diagnose or rule out other sleep disorders including RLS, periodic limb movement disorder, and parasomnias. Required for complex cases, CPAP titration in some protocols, and pediatric evaluations.
Key diagnostic numbers: The Apnea-Hypopnea Index (AHI) quantifies severity. An AHI of 5–14 is mild OSA; 15–29 is moderate; 30+ is severe. The oxygen desaturation index (ODI) — how often oxygen drops ≥3–4% — is also clinically important. If your AHI is ≥5 with symptoms, or ≥15 without symptoms, treatment is recommended by AASM guidelines.
What Works Sleep Apnea Treatment Options
Treatment is tiered by OSA severity and individual factors. CPAP therapy is the most evidence-supported treatment for moderate-to-severe OSA and is the standard first-line approach for anyone with AHI ≥15 or AHI ≥5 with significant symptoms.
| Treatment | Best For | Key Notes |
|---|---|---|
| CPAP Therapy | Moderate-to-severe OSA; first-line standard of care | Most effective treatment; requires mask adherence; modern devices are quieter and more comfortable than older designs |
| Auto-CPAP (APAP) | OSA where optimal pressure varies night to night | Adjusts pressure automatically; often preferred for home use over fixed-pressure CPAP |
| BiPAP | People who can't tolerate CPAP pressure; CSA | Different pressures for inhale and exhale; also used for complex and central apnea |
| Adaptive Servo-Ventilation (ASV) | Central sleep apnea; complex/mixed apnea | Delivers a breath as needed; not recommended for heart failure with reduced ejection fraction (SERVE-HF trial) |
| Oral Appliance (MAD) | Mild-moderate OSA; CPAP-intolerant patients | Mandibular advancement device advances the lower jaw; custom-fitted by a dental sleep specialist; less effective than CPAP for severe OSA |
| Positional Therapy | Position-dependent OSA (worse supine) | Devices that prevent back-sleeping; effective for the ~25% of OSA patients whose apnea is primarily positional |
| Hypoglossal Nerve Stimulator (Inspire) | Moderate-severe OSA; CPAP-intolerant | Implanted device that stimulates tongue muscles during sleep; FDA-approved; requires surgery; effective in appropriate candidates |
| Weight Loss | OSA in overweight/obese patients | Can significantly reduce AHI; 10% weight loss reduces AHI by ~26%; may resolve OSA entirely in some patients |
| Surgery (various) | Anatomical obstruction; CPAP failure | Last resort; options include UPPP, tonsillectomy, nasal surgery, maxillomandibular advancement; variable outcomes |
CPAP adherence is the real challenge: CPAP is highly effective when used — but adherence is a significant clinical problem. Research in Sleep estimates 30–50% of patients are non-adherent within 1–3 years. Modern CPAP machines are significantly more comfortable, quieter, and data-connected than older models. If you've tried CPAP and stopped, it's worth discussing mask fit, pressure settings, and humidification with your sleep physician before assuming the treatment isn't right for you.
Sleep apnea and insomnia frequently coexist: Many people with OSA also develop behavioral insomnia — from years of conditioned arousal and sleep anxiety around the breathing disruptions. CPAP treats the apnea but not the conditioned wakefulness that has developed alongside it. If you have sleep apnea and are struggling with insomnia despite CPAP therapy, CBT-I addresses the behavioral insomnia layer that CPAP does not.
